by Admin | Jan 17, 2020 | News & Opinions
By Mike Moradi, Co-Founder & CEO, Sensulin for World Economic Forum The current market for stem cell therapies is growing at 36% per year and will rapidly expand when a breakthrough treatment for non-communicable disease or a lifestyle factor occurs. Funding is...
by Admin | Jan 15, 2020 | News & Opinions
Image Caption: The research team (left to right): Jia-Shiuan Tsai, Meng-chieh Lin, Wen-Ting Luo, Hua-Jung Li, Pei-Lin He, Shih-Yin Chen Durham, NC – When it comes to regenerating damaged brain cells, mesenchymal stem cells (MSCs) induced using an EP4 antagonist are...
by Admin | Jan 13, 2020 | News & Opinions
Will Hoh, Alan Jakimo and Russ Steward Join H.C. Wainwright as Managing Directors of M&A and Strategic Advisory Services January 12, 2020 06:00 PM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–H.C. Wainwright & Co., LLC (“HCW” or the “Company”), a...
by Admin | Jan 11, 2020 | News & Opinions
Porous coordination polymers can be a form of carbon-capture technology, says discoverer Susumu Kitagawa, second from left, with (left to right) Atomis CTO Masakazu Higuchi, CEO Daisuke Asari, R&D officer Kenji Sumida, and COO Dai Kataoka. (Japan BrandVoice) As...
by Admin | Jan 10, 2020 | News & Opinions
ROCHESTER, Minn. — A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis (MS), Mayo Clinic researchers discovered. The early research in animal models could advance an...